RESUMEN
Objective: The aim of this study was to determine the cardiometabolic risk factors in different polycystic ovary syndrome [PCOS] phenotypes
Subjects and Methods: This cross-sectional study was performed between 2010 and 2011. Eighty-nine patients with PCOS and 25 age- and weight-matched healthy controls were included in the study. Patients were grouped using the Rotterdam 2003 criteria as: group 1, oligomenorrhea and/or anovulation [ANOV] and hyperandrogenemia [HA] and/or hyperandrogenism [n = 23]; group 2, ANOV and polycystic ovaries [PCO; n = 22]; group 3, HA and PCO [n = 22]; group 4, ANOV, HA and PCO [n = 22]; group 5, controls [n = 25]. Laboratory blood tests for diagnosis and cardiometabolic risk assessments were performed. Insulin resistance [IR] was calculated in all patients with the homeostasis model assessment of IR [HOMA-IR] formula. An euglycemic hyperinsulinemic clamp test was performed on 5 randomly selected cases in each subgroup, making 25 cases in total, and indicated as the 'M' value [mg/kg/min], which is the total body glucose disposal rate
Results: The mean BMl values of the groups were: group 1, 26.1 +/- 5.3; group 2, 27.9 +/- 5.2; group 3, 24.3 +/- 4.2; group 4, 27.9 +/- 7.5; group 5, 24.7 +/- 5.2 [p > 0.05]. There were no differences in the lipid profile, plasma glucose, HOMA-IR, insulin and M values between the groups [p > 0.05]. Phenotypes with oligomenorrhea/anovulation [groups 1, 2 and 4] were more obese than group 3 [p = 0.039]
Conclusions: The cardiometabolic risk profile was similar among the PCOS subgroups. This finding could be attributed to the mean BMl values, which, being below 30, were not within the obesity range. Obesity appeared to be an important determinant of high cardiovascular risk in PCOS